NWBO Northwest Biotherapeutics, Inc.
$0.17
Northwest Biotherapeutics, Inc. (NWBO) is expected to report earnings on November 12, 2026, after the market close.
Northwest Biotherapeutics Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.
Sector
Healthcare